Baxalta Cancels Partnership Deal With Onconova Therapeutics

Baxalta backs out of deal for rigosertib despite ongoing clinical trials, effective August 30.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.